A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 64
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AA
Long Form : advanced adenoma
No. Year Title Co-occurring Abbreviation
2020 A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2. CRC
2020 Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection. CRC, mSDC2, mSEPT9
2020 Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance. CRC
2020 Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge. CRC, ctDNA, iFOBT, NAA
2020 Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors. AN, ASL, AUC, CI, CRC, FIT10, HL
2020 Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects. CRC, FIT
2020 Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer. AUCs, CRC
2020 Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer. CRC
2020 Plausibility of an extensive use of stool DNA test for screening advanced colorectal neoplasia. CRC, FIT, NAA, NC
10  2020 Prevalence of colorectal cancer and advanced adenoma in patients with acute diverticulitis: implications for follow-up colonoscopy. CRC, UPMC
11  2020 Prospective colonoscopic study to investigate risk of colorectal neoplasms in first-degree relatives of patients with non-advanced adenomas. FDR, mOR, non-AA
12  2020 Serum netrin-1 as a biomarker for colorectal cancer detection. CRC
13  2020 The Impact of Transitioning From Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program. CI, CRC, FIT, gFOBT, OR
14  2020 Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer. CRC, FIT
15  2019 Analysis of A 6-Mirna Signature in Serum from Colorectal Cancer Screening Participants as Non-Invasive Biomarkers for Advanced Adenoma and Colorectal Cancer Detection. AUC, CRC, FIT
16  2019 Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study. CRC, f-Hb, FAST, FAST score, FIT, IBD, SBD
17  2019 Association of small versus diminutive adenomas and the risk for metachronous advanced adenomas: data from the New Hampshire Colonoscopy Registry. AOR, CI, CRC, NHCR
18  2019 Coexistent adenoma and serrated polyps on index colonoscopy and the risk of metachronous advanced colorectal neoplasia. CI, CRN, HP, HR, SP
19  2019 Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients. AC, AUC, CRC, CV, FIT, FITs, gFOBT, gFOBT, HS, NPV, PPV, Se, Sp
20  2019 Early diagnosis of colorectal cancer via plasma proteomic analysis of CRC and advanced adenomatous polyp. CRC
21  2019 Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives. AN, CRC, FIT, Hb
22  2019 Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels. AN, CRC, FIT, Hb
23  2019 Fecal volatile organic compounds for early detection of colorectal cancer: where are we now? CRC, VOCs
24  2019 Follow up colonoscopy may be omissible in uncomplicated left-sided acute diverticulitis diagnosed with CT- a retrospective cohort study. CRC
25  2019 GPs' perspectives on colorectal cancer screening and their potential influence on FIT-positive patients: an exploratory qualitative study from a Dutch context. CRC, FIT
26  2019 Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening. CRC, HP
27  2019 Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. CRC, FIT, mt-sDNA
28  2019 Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. CRC, miRNA, SVM
29  2018 An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer. ACRN, CI, CRC, f-Hb
30  2018 Analytical validation of a novel multiplex test for detection of advanced adenoma and colorectal cancer in symptomatic patients. CAP, CLIA, CRC, LDT
31  2018 Appropriateness and yield of surveillance colonoscopy in first-degree relatives of colorectal cancer patients: A 5-year follow-up population-based study. CRC, FDRs, FH, NAA
32  2018 Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer. ASSA, CRC, TSA
33  2018 Correlating colorectal cancer risk with field carcinogenesis progression using partial wave spectroscopic microscopy. CRC, NDA, PWS
34  2018 Factors related to colorectal cancer in advanced adenomas and serrated polyps: a further step toward individualized surveillance. CRC, SP
35  2018 Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening. AN, AUC, CRC, FIT
36  2018 Number of advanced adenomas on index colonoscopy: Important risk factor for metachronous advanced colorectal neoplasia. CRN
37  2018 Proteomic Profiling for Colorectal Cancer Biomarker Discovery. CRC, MS, NDKA
38  2018 Quantitative fecal immunochemical tests for colorectal cancer screening. AN, CRC, FITs, Hb, PRs, ROC
39  2018 Results of the national organised colorectal cancer screening program with FIT in Paris. CRC, FIT, PPV
40  2018 Risk of advanced colorectal neoplasm by the proposed combined United States and United Kingdom risk stratification guidelines. CRN, non-AAs
41  2017 Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling. CRC, FITs, FS
42  2017 Is methylation analysis of SFRP2, TFPI2, NDRG4, and BMP3 promoters suitable for colorectal cancer screening in the Korean population? CRC
43  2017 Routine Colonoscopy after Acute Uncomplicated Diverticulitis - Challenging a Putative Indication. ACN, CRC
44  2017 The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations. CI, CRC, HIR, HR, IR, LIR, OR, PYs
45  2017 The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening. NAA
46  2017 [Lesions Detected in Six Spanish Colorectal Cancer Screening Population Based Programmes. CRIBEA Project. Spain]. AN, CRC, FOBT
47  2016 Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle. CRC
48  2016 Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening. CRC, DR, FIT
49  2016 Low rate of advanced adenoma formation during a 5-year colonoscopy surveillance period after adequate polypectomy of non-advanced adenoma. NAA
50  2016 Paneth Cell in Adenomas of the Distal Colorectum Is Inversely Associated with Synchronous Advanced Adenoma and Carcinoma. CRC, OR
51  2016 Prevalence of colorectal neoplasms in young, average risk individuals: A turning tide between East and West. CRC
52  2016 [Serrated polyps and their association with synchronous advanced colorectal neoplasia]. ACN, BMI, OR, SP, SPIRML, SSA/P
53  2015 Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening. AN, cMMP-9, CRC, FIT, MMP-9
54  2015 Yield of colonoscopy after recent CT-proven uncomplicated acute diverticulitis: a comparative cohort study. ACN, CRC, OR
55  2013 Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia. FIT
56  2013 Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. CRC, sDNA
57  2013 Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. CIs, CRC, NAA, ORs
58  2013 Reproducibility of the villous component and high-grade dysplasia in colorectal adenomas <1 cm: implications for endoscopic surveillance. GI, HGD, VC
59  2010 Cost-effectiveness of colorectal cancer screening with computed tomography colonography according to a polyp size threshold for polypectomy. CRC, CTC, ICER, LYG
60  2010 Utilization of surveillance colonoscopy in community practice. NAA
61  2009 Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer. CRC, HPP, NAA
62  2007 Screening for colorectal cancer in Italy: 2005 survey. DR, FOBT, PPV
63  2007 [High-grade dysplasia as a risk factor of metachronous advanced colorectal neoplasms in patients with advanced adenomas]. CRC, HGD
64  2006 Detection of stool DNA mutations before and after treatment of colorectal neoplasia. DIA, MTAP